NPI-3114

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNPI-3114
Drug Alias Nameactinomycete-derived chloronated bisindole pyrrole derivatives (Nereus)NPI-3114
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNereus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNereus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A